id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289553-gygvhzcc	Alvarez, Roger A.	Home Nitric Oxide Therapy for COVID-19	2020-07-01		.txt	text/plain	1825	89	43	130-132) present an interesting and compelling case of a patient with pulmonary arterial hypertension (PAH) who was treated remotely in an ambulatory setting with inhaled nitric oxide (iNO) (5) . In a randomized and placebo-controlled trial of ambulatory patients with fibrotic lung disease requiring long-term oxygen, INOpulse therapy was associated with greater physical activity than placebo, and in an acute dose escalation study of patients with pulmonary hypertension associated with pulmonary fibrosis, iNO delivered through the INOpulse system lead to a 30% reduction in pulmonary vascular resistance, with improvements in Q _ and pulmonary artery compliance (15) . The Hestia criteria identified a cohort of patients with acute PE who completed outpatient therapy with a low risk of adverse events, including recurrent venous thromboembolism (2%), all-cause mortality (1%), and major bleeding (0.7%).	./cache/cord-289553-gygvhzcc.txt	./txt/cord-289553-gygvhzcc.txt